Should Non-Nucleoside Reverse Transcriptase Inhibitors be Combined?

By Kappelhoff Bregt S.   Huitema Alwin D.R.   Beijnen Jos H.  

Drugs in R&D, Vol. 6, Iss. 2, 2005-01 ,pp. : 61-69

Adis International

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors

By Smith P.F.  

Clinical Pharmacokinetics, Vol. 40, Iss. 12, 2001-01 ,pp. : 893-905

Adis International

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M.   Morrison I.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors

By Ma Qing   Okusanya Olanrewaju O   Smith Patrick F   DiCenzo Robert   Slish Judianne C   Catanzaro Linda M   Forrest Alan   Morse Gene D  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 473-485

Informa Healthcare

Access to resources Recommend Favorite